• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪酸生物合成的II型途径为恶性疟原虫提供了药物靶点。

A type II pathway for fatty acid biosynthesis presents drug targets in Plasmodium falciparum.

作者信息

Waller Ross F, Ralph Stuart A, Reed Michael B, Su Vanessa, Douglas James D, Minnikin David E, Cowman Alan F, Besra Gurdyal S, McFadden Geoffrey I

机构信息

School of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Victoria 3010, Australia.

出版信息

Antimicrob Agents Chemother. 2003 Jan;47(1):297-301. doi: 10.1128/AAC.47.1.297-301.2003.

DOI:10.1128/AAC.47.1.297-301.2003
PMID:12499205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC148988/
Abstract

It has long been held that the malaria parasite, Plasmodium sp., is incapable of de novo fatty acid synthesis. This view has recently been overturned with the emergence of data for the presence of a fatty acid biosynthetic pathway in the relict plastid of P. falciparum (known as the apicoplast). This pathway represents the type II pathway common to plant chloroplasts and bacteria but distinct from the type I pathway of animals including humans. Specific inhibitors of the type II pathway, thiolactomycin and triclosan, have been reported to target this Plasmodium pathway. Here we report further inhibitors of the plastid-based pathway that inhibit Plasmodium parasites. These include several analogues of thiolactomycin, two with sixfold-greater efficacy than thiolactomycin. We also report that parasites respond very rapidly to such inhibitors and that the greatest sensitivity is seen in ring-stage parasites. This study substantiates the importance of fatty acid synthesis for blood-stage parasite survival and shows that this pathway provides scope for the development of novel antimalarial drugs.

摘要

长期以来,人们一直认为疟原虫属的疟原虫无法进行脂肪酸的从头合成。最近,随着恶性疟原虫(称为顶质体)残留质体中存在脂肪酸生物合成途径的数据出现,这一观点被推翻。该途径代表了植物叶绿体和细菌共有的II型途径,但不同于包括人类在内的动物的I型途径。据报道,II型途径的特异性抑制剂硫内酯霉素和三氯生可作用于这种疟原虫途径。在此,我们报告了抑制疟原虫寄生虫的基于质体途径的其他抑制剂。这些包括硫内酯霉素的几种类似物,其中两种的效力比硫内酯霉素高六倍。我们还报告说,寄生虫对这类抑制剂反应非常迅速,并且在环状体期寄生虫中观察到最大的敏感性。这项研究证实了脂肪酸合成对血液期寄生虫存活的重要性,并表明该途径为新型抗疟药物的开发提供了空间。

相似文献

1
A type II pathway for fatty acid biosynthesis presents drug targets in Plasmodium falciparum.脂肪酸生物合成的II型途径为恶性疟原虫提供了药物靶点。
Antimicrob Agents Chemother. 2003 Jan;47(1):297-301. doi: 10.1128/AAC.47.1.297-301.2003.
2
Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum.核编码蛋白靶向刚地弓形虫和恶性疟原虫中的质体。
Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12352-7. doi: 10.1073/pnas.95.21.12352.
3
Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites.利用化学补充测定法在培养的人类疟疾寄生虫中验证潜在的质体靶向药物。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01161-17. Print 2018 Jan.
4
Understanding the biology of the Plasmodium falciparum apicoplast; an excellent target for antimalarial drug development.了解恶性疟原虫质体的生物学特性;这是抗疟药物研发的一个极好靶点。
Life Sci. 2016 Aug 1;158:104-10. doi: 10.1016/j.lfs.2016.06.030. Epub 2016 Jul 2.
5
The plastid of Plasmodium spp.: a target for inhibitors.
Curr Top Microbiol Immunol. 2005;295:251-73. doi: 10.1007/3-540-29088-5_10.
6
Characterization of the Plasmodium falciparum and P. berghei glycerol 3-phosphate acyltransferase involved in FASII fatty acid utilization in the malaria parasite apicoplast.恶性疟原虫和伯氏疟原虫甘油-3-磷酸酰基转移酶的特性研究,该酶参与疟原虫顶质体中II型脂肪酸合成途径的脂肪酸利用过程。
Cell Microbiol. 2017 Jan;19(1). doi: 10.1111/cmi.12633. Epub 2016 Aug 1.
7
Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.抗疟药物及疟原虫脂肪酸代谢途径的药物靶点。
Chem Biol Drug Des. 2012 Aug;80(2):155-72. doi: 10.1111/j.1747-0285.2012.01389.x. Epub 2012 May 28.
8
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.顶质体非管家功能的抑制剂可抵抗恶性疟原虫的延迟死亡。
Antimicrob Agents Chemother. 2007 Jan;51(1):307-16. doi: 10.1128/AAC.00808-06. Epub 2006 Oct 23.
9
Triclosan inhibit the growth of the late liver-stage of Plasmodium.三氯生抑制疟原虫肝晚期的生长。
IUBMB Life. 2009 Sep;61(9):923-8. doi: 10.1002/iub.237.
10
Paradigm shifts in malaria parasite biochemistry and anti-malarial chemotherapy.疟原虫生物化学与抗疟化疗的范式转变
Bioessays. 2002 Feb;24(2):192-6. doi: 10.1002/bies.10042.

引用本文的文献

1
Hemozoin: a waste product after heme detoxification?疟原虫色素:血红素解毒后的废物?
Parasit Vectors. 2025 Mar 4;18(1):83. doi: 10.1186/s13071-025-06699-x.
2
Application of Machine Learning in the Development of Fourth Degree Quantitative Structure-Activity Relationship Model for Triclosan Analogs Tested against 3D7.机器学习在三氯生类似物针对3D7测试的四阶定量构效关系模型开发中的应用。
ACS Omega. 2024 Oct 25;9(44):44436-44447. doi: 10.1021/acsomega.4c05768. eCollection 2024 Nov 5.
3
To quest new targets of parasite and their potential inhibitors to combat antimalarial drug resistance.探寻疟原虫的新靶点及其对抗疟药耐药性的潜在抑制剂。
J Parasit Dis. 2024 Dec;48(4):671-722. doi: 10.1007/s12639-024-01687-x. Epub 2024 May 31.
4
Apicoplast-Resident Processes: Exploiting the Chink in the Armour of Parasites.顶质体驻留过程:利用寄生虫防护中的薄弱环节
Adv Pharmacol Pharm Sci. 2024 May 10;2024:9940468. doi: 10.1155/2024/9940468. eCollection 2024.
5
antimalarial activity of fruit fraction.果实部分的抗疟活性。
Open Vet J. 2023 Sep;13(9):1116-1123. doi: 10.5455/OVJ.2023.v13.i9.7. Epub 2023 Sep 30.
6
Antimalarial drug discovery: progress and approaches.抗疟药物发现:进展与方法。
Nat Rev Drug Discov. 2023 Oct;22(10):807-826. doi: 10.1038/s41573-023-00772-9. Epub 2023 Aug 31.
7
Protein kinases on carbon metabolism: potential targets for alternative chemotherapies against toxoplasmosis.碳代谢中的蛋白激酶:弓形虫病替代化疗的潜在靶点。
Front Cell Infect Microbiol. 2023 May 23;13:1175409. doi: 10.3389/fcimb.2023.1175409. eCollection 2023.
8
Chemogenomic Profiling of a Plasmodium falciparum Transposon Mutant Library Reveals Shared Effects of Dihydroartemisinin and Bortezomib on Lipid Metabolism and Exported Proteins.疟原虫转座子突变体文库的化学基因组学分析揭示了双氢青蒿素和硼替佐米对脂代谢和分泌蛋白的共同作用。
Microbiol Spectr. 2023 Jun 15;11(3):e0501422. doi: 10.1128/spectrum.05014-22. Epub 2023 Apr 17.
9
Expression of the Fab enzymes (Fab I and Fab Z) from after exposure to plant extracts and drugs screening.暴露于植物提取物并进行药物筛选后,Fab酶(Fab I和Fab Z)的表达。
J Parasit Dis. 2023 Mar;47(1):46-58. doi: 10.1007/s12639-022-01537-8. Epub 2022 Oct 13.
10
Selection of an Aptamer against the Enzyme 1-deoxy-D-xylulose-5-phosphate Reductoisomerase from .从……中筛选针对1-脱氧-D-木酮糖-5-磷酸还原异构酶的适配体
Pharmaceutics. 2022 Nov 19;14(11):2515. doi: 10.3390/pharmaceutics14112515.

本文引用的文献

1
Genome sequence of the human malaria parasite Plasmodium falciparum.人类疟原虫恶性疟原虫的基因组序列。
Nature. 2002 Oct 3;419(6906):498-511. doi: 10.1038/nature01097.
2
A High-Resolution Gene Map of the Chloroplast Genome of the Red Alga Porphyra purpurea.紫紫菜叶绿体基因组的高分辨率基因图谱
Plant Cell. 1993 Apr;5(4):465-475. doi: 10.1105/tpc.5.4.465.
3
Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase.抗菌剂三氯生对疟疾烯酰酰基载体蛋白还原酶特异性的结构解析。
J Biol Chem. 2002 Apr 12;277(15):13106-14. doi: 10.1074/jbc.M112000200. Epub 2002 Jan 15.
4
The apicoplast as an antimalarial drug target.顶质体作为抗疟药物靶点。
Drug Resist Updat. 2001 Jun;4(3):145-51. doi: 10.1054/drup.2001.0205.
5
Structure of beta-ketoacyl-[acyl carrier protein] reductase from Escherichia coli: negative cooperativity and its structural basis.来自大肠杆菌的β-酮酰基-[酰基载体蛋白]还原酶的结构:负协同性及其结构基础。
Biochemistry. 2001 Oct 30;40(43):12772-81. doi: 10.1021/bi010737g.
6
An isoleucine/leucine residue in the carboxyltransferase domain of acetyl-CoA carboxylase is critical for interaction with aryloxyphenoxypropionate and cyclohexanedione inhibitors.乙酰辅酶A羧化酶的羧基转移酶结构域中的异亮氨酸/亮氨酸残基对于与芳氧苯氧丙酸酯和环己二酮抑制剂的相互作用至关重要。
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6617-22. doi: 10.1073/pnas.121172798. Epub 2001 May 29.
7
Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I.三氯生通过抑制顶复门脂肪酸合酶I来抑制恶性疟原虫和刚地弓形虫的生长。
Int J Parasitol. 2001 Feb;31(2):109-13. doi: 10.1016/s0020-7519(01)00111-4.
8
Subcellular localization of acetyl-CoA carboxylase in the apicomplexan parasite Toxoplasma gondii.顶复门寄生虫刚地弓形虫中乙酰辅酶A羧化酶的亚细胞定位
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2723-8. doi: 10.1073/pnas.051629998. Epub 2001 Feb 13.
9
Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.三氯生通过抑制恶性疟原虫的烯酰-ACP还原酶,为疟疾的血液阶段提供保护。
Nat Med. 2001 Feb;7(2):167-73. doi: 10.1038/84612.
10
Protein trafficking to the plastid of Plasmodium falciparum is via the secretory pathway.恶性疟原虫的蛋白质转运至质体是通过分泌途径进行的。
EMBO J. 2000 Apr 17;19(8):1794-802. doi: 10.1093/emboj/19.8.1794.